Silexion Therapeutics Corp (SLXN) concluded trading on Thursday at a closing price of $1.44, with 7.66 million shares of worth about $11.03 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -98.69% during that period and on February 06, 2025 the price saw a gain of about 5.11%. Currently the company’s common shares owned by public are about 4.00M shares, out of which, 2.10M shares are available for trading.
Stock saw a price change of -29.76% in past 5 days and over the past one month there was a price change of -36.28%. Year-to-date (YTD), SLXN shares are showing a performance of -28.36% which decreased to -98.43% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.57 but also hit the highest price of $122.02 during that period. The average intraday trading volume for Silexion Therapeutics Corp shares is 11.23 million. The stock is currently trading 1.54% above its 20-day simple moving average (SMA20), while that difference is down -33.23% for SMA50 and it goes to -96.69% lower than SMA200.
Silexion Therapeutics Corp (NASDAQ: SLXN) currently have 4.00M outstanding shares and institutions hold larger chunk of about 11.73% of that.
The stock has a current market capitalization of $5.75M and its 3Y-monthly beta is at 0.03. It has posted earnings per share of -$19.71 in the same period. It has Quick Ratio of 0.85. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SLXN, volatility over the week remained 26.94% while standing at 24.80% over the month.
